Monthly Investment Planning for Long-Term Success
Wegovy or Mounjaro Better for Budget Planning?
When evaluating whether Wegovy or Mounjaro better suits your monthly budget, understanding the complete cost journey is crucial. Wegovy follows a structured 16-week dose escalation, starting at £79.99 monthly for the 0.25mg starter dose, progressing to £94.99 for weeks 5-8 (0.5mg), then £99.99 for weeks 9-12 (1mg), followed by £139.99 for weeks 13-16 (1.7mg), before reaching the maintenance dose of £209.99 monthly from week 17 onwards. This gradual increase allows your body to adjust whilst providing predictable monthly costs for financial planning.
Mounjaro follows a different pricing structure with its tirzepatide formulation, though both treatments require similar long-term financial commitment for sustained weight management. The key difference lies in Wegovy's proven track record and established dosing protocol, versus Mounjaro's dual GIP and GLP-1 receptor mechanism. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which better aligns with your clinical needs and monthly budget expectations.
UK Pricing Structure: Wegovy or Mounjaro Better Value?
EverydayMeds provides transparent pricing for both treatment options, with Wegovy's monthly costs clearly defined across each escalation phase. New customers benefit from the FIRST40 discount code applied at checkout, bringing the starter month to £79.99, whilst returning customers maintain competitive rates with DOSE25 for ongoing monthly supplies. The annual maintenance cost for Wegovy at 2.4mg totals £2,519.88, representing a clear monthly investment of £209.99 once you reach the therapeutic dose.
Bundle options provide additional convenience for monthly planning, with our Getting Started Duo combining your first two months (0.25mg and 0.5mg) for £169.99, whilst the Ultimate Stability Trio provides three months of maintenance supply (2.4mg × 3) for £649.99. These bundles prioritise convenience and Reliable Supply continuity rather than cost savings, ensuring uninterrupted treatment without monthly reordering concerns. Your GPhC-registered pharmacy (#9012878) ensures all deliveries maintain cold-chain integrity for optimal medication efficacy.
Clinical Evidence: Which Treatment Better Supports Weight Goals?
In the landmark STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of 15.2% at two years, indicating long-term efficacy that may justify the monthly investment for eligible patients.
Mounjaro's clinical trials show different endpoints and patient populations, making direct comparison challenging without proper clinical context. Both treatments require ongoing monthly commitment, with weight regain studies suggesting patients regained approximately two-thirds of weight lost within one year of stopping treatment. This emphasises that monthly costs represent a long-term investment in sustained weight management rather than a temporary expense.
How Wegovy Works: Understanding Your Monthly Investment
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management goals. The medication works by reducing appetite and promoting feelings of fullness after smaller meals, potentially reducing food cravings through its action on brain appetite centres. This mechanism requires consistent weekly dosing to maintain therapeutic levels, explaining why monthly treatment represents an ongoing commitment rather than a short-term intervention. The prescription-only medicine must be used alongside a reduced-calorie diet and increased physical activity for optimal results. Understanding this mechanism helps justify the monthly investment as supporting your body's natural appetite regulation rather than providing temporary weight loss effects.
Ordering Process: Accessing Monthly Supplies
EverydayMeds streamlines access to both Wegovy and Mounjaro through a three-minute online clinical assessment, followed by prescriber review within three working days (or 24 hours with express service). Once approved, next-day cold-chain delivery ensures your monthly supply arrives in optimal condition, maintaining the medication's efficacy throughout transport and storage. The process includes automatic reminders for monthly reordering, though bundle options can extend this to quarterly deliveries for maintenance doses. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet UK regulatory standards, with clinical oversight for ongoing treatment monitoring.
Storage and Practical Considerations for Monthly Planning
Wegovy requires refrigerated storage at 2-8°C before first use, though it can remain at room temperature below 30°C for up to six weeks once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit provides greater flexibility for travel and daily use, potentially reducing medication waste and associated monthly costs. The FlexTouch pen design simplifies weekly injections, whilst the mandatory dose escalation protocol ensures your body adjusts gradually to each monthly dose increase. Understanding these practical aspects helps optimise your monthly investment by preventing storage-related medication loss.
Is Wegovy or Mounjaro Better for Long-Term Budgeting?
Long-term financial planning requires understanding both treatments' maintenance phase costs, with Wegovy's £209.99 monthly maintenance dose providing clear budgeting certainty from week 17 onwards. The structured escalation means your highest monthly cost is predetermined, allowing accurate annual budgeting of £2,519.88 for maintenance therapy. Bundle options like the Ultimate Stability Trio can shift monthly payments to quarterly intervals, potentially easing cash flow management whilst maintaining treatment continuity.
The DOSE25 discount for returning customers ensures competitive monthly rates remain accessible throughout your treatment journey, whilst various bundle combinations accommodate different financial planning preferences. Whether Wegovy or Mounjaro better suits your long-term budget depends on individual clinical response, tolerability, and prescriber recommendation rather than price alone, as both represent significant monthly investments in sustained weight management.
Making Your Treatment Decision
Both Wegovy and Mounjaro are available from EverydayMeds with transparent monthly pricing and flexible bundle options to support your weight management journey. Your prescriber will consider clinical factors, treatment history, and individual response patterns when determining which treatment may better suit your needs. The monthly investment reflects ongoing support for sustainable weight management rather than quick-fix solutions, with clinical evidence supporting long-term commitment for optimal results. Start your clinical assessment today using discount code FIRST40 for new customers, or DOSE25 for returning customers, and discover which treatment aligns with your monthly budget and clinical goals through our expert prescriber review process.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
